Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 22;15(1):2745.
doi: 10.1038/s41598-025-86612-9.

Association of the triglyceride glucose index with all cause and CVD mortality in the adults with diabetes aged < 65 years without cardiovascular disease

Affiliations

Association of the triglyceride glucose index with all cause and CVD mortality in the adults with diabetes aged < 65 years without cardiovascular disease

Chang Liu et al. Sci Rep. .

Abstract

Although the triglyceride-glucose (TyG) index has been established as a valuable predictor for cardiovascular disease (CVD) and cardiovascular mortality, there is limited research exploring its association with all-cause or CVD mortality specifically in adults with diabetes aged < 65 years without cardiovascular disease. This study aimed to investigate the relationship between the TyG index and both all-cause and CVD mortality in this population within the United States. Our study recruited 1778 adults with diabetes aged < 65 years without cardiovascular disease from the National Health and Nutrition Examination Survey (NHANES) 2003-2018. Mortality outcomes were determined by linking to National Death Index (NDI) records up to December 31, 2019. Cox regression modeling was employed to examine the association between the TyG index and mortality in this population. The nonlinear relationship between the TyG index and mortality was assessed using restricted cubic splines (RCS). Additionally, subgroup analyses and interaction tests were conducted to explore potential effect modifiers. A total of 1788 participants were included in the final cohort, with an average age of 49.61 ± 0.32 years. During a median follow-up of 7.92 years, the occurrence of 150 all-cause deaths and 33 CVD-related deaths were recorded. To investigate the independent association between the TyG index and the risks of all-cause and CVD mortality, three Cox regression models were developed. In Model 1, a significant positive association was observed between the TyG index and the risk of all-cause mortality (HR 1.38, 95% CI 1.09-1.74). This association persisted in the minimally adjusted model (HR 1.44, 95% CI 1.13-1.83), which was adjusted for age, gender and race. Even after full adjustment, this positive association remained significant (HR 1.91, 95% CI 1.36-2.70). We also found that the relationship between the TyG index and all-cause mortality was linear. Subgroup analyses revealed no significant interactions between the TyG index and the stratification variables. However, we did not observe a significant association between the TyG index and CVD mortality in this population. Our results suggested that a significantly positive association between the TyG index and all-cause mortality. The positive association between the TyG index and all-cause mortality was linear. We did not observe a significant association between the TyG index and CVD mortality.

Keywords: CVD; Diabetes; Mortality; TyG index.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethics statement: The studies involving human participants were reviewed and approved by the NCHS Research Ethics Review Board (ERB). All participants provided written informed consent.

Figures

Fig. 1
Fig. 1
Flowchart of the sample selection from National Health and Nutrition Examination Survey (NHANES) 2003–2018.
Fig. 2
Fig. 2
The Restricted cubic spline (RCS) analysis between the TyG index and all-cause mortality.
Fig. 3
Fig. 3
Subgroup analysis of the association between the TyG index and all-cause mortality.

Similar articles

Cited by

References

    1. Cho, N. H. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract138, 271–281 (2018). - PubMed
    1. Lebovitz, H. E. Insulin resistance: Definition and consequences. Exp Clin Endocrinol Diabetes109(Suppl 2), S135-148 (2001). - PubMed
    1. Kosmas, C. E. et al. Insulin resistance and cardiovascular disease. J Int Med Res51(3), 3000605231164548 (2023). - PMC - PubMed
    1. Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. & Dekkers, O. M. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: Meta-analysis. PLoS One7(12), e52036 (2012). - PMC - PubMed
    1. Wallace, T. M. & Matthews, D. R. The assessment of insulin resistance in man. Diabet Med19(7), 527–534 (2002). - PubMed

Publication types

LinkOut - more resources